A Phase 4 Double-Blind Randomized Placebo-controlled Multi-Center Study to Evaluate the Efficacy Safety and Tolerability of Mirabegron in Men with Overactive Bladder (OAB) Symptoms While Taking the Alpha Blocker Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH)
-
- STATUS
- Not Recruiting
Summary
The purpose of this study is to see if a medicine called mirabegron (MYRBETRIQ) is effective, safe, and tolerated as a treatment for reducing overactive bladder (OAB) symptoms while taking tamsulosin hydrochloride for lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia(BPH).
Description
The purpose of this study is to see if a medicine called mirabegron (MYRBETRIQ) is effective, safe, and tolerated as a treatment for reducing overactive bladder (OAB) symptoms while taking tamsulosin hydrochloride for lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia(BPH).
Details
| Condition | overactive bladder,benign prostatic hyperplasia |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX6749 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.